Carbidopa
6 NDCs across 6 manufacturers|5 Generic,1 Brand
Carbidopa is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Mar 10, 2014. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $7 million on Carbidopa across 22,000 claims for 5,758 beneficiaries.
Carbidopa is available as 6 NDCs from 6 manufacturers (5 generic, 1 brand), with NADAC prices from $0.54 to $25.72 per EA — the most expensive product costs about 48× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
5G / 1B
Manufacturers
6
competing in market
Price Spread
$0.54 – $25.72
per EA
7d Activity
avg +0.7% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch Health US LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing CARBIDOPA(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LODOSYN 25 MG TABLET | $25.7206 per EA | — |
CARBIDOPA 25 MG TABLET | $1.1037 per EA | — |
CARBIDOPA 25 MG TABLET | $0.5360 per EA | +0.65% |
CARBIDOPA 25 MG TABLET | $0.5360 per EA | +0.65% |
CARBIDOPA 25 MG TABLET | $0.5360 per EA | +0.65% |
CARBIDOPA 25 MG TABLET | $0.5360 per EA | +0.65% |
Frequently Asked Questions
What is Carbidopa used to treat?
Carbidopa is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Carbidopa become available as a generic?
FDA approved the first generic Carbidopa (ANDA) on Mar 10, 2014. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Carbidopa?
In 2024, Medicare Part D spent $7 million on Carbidopa across 22,000 claims for 5,758 beneficiaries.
How many Carbidopa products are on the market?
The Carbidopa drug market contains 6 NDCs from 6 manufacturers — 5 generic and 1 brand product.
What is the price range for Carbidopa?
NADAC reference prices for Carbidopa range from $0.5360 to $25.7206 per EA — the most expensive product costs about 48× the cheapest.
Is generic Carbidopa cheaper than brand?
The average generic NADAC for Carbidopa is $0.6495 per EA, versus $25.7206 for brand-labeled products — brand versions average about 40× the generic price.
Which manufacturers make Carbidopa?
6 manufacturers list Carbidopa in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (1), Lupin Pharmaceuticals Inc. (1), NorthStar Rx LLC (1), Edenbridge Pharmaceuticals LLC (1), Aurobindo Pharma Limited (1).
How has the price of Carbidopa changed recently?
Over the past 7 days, 4 Carbidopa NDCs rose and 0 fell, with a market-wide average change of +0.7%.